255 related articles for article (PubMed ID: 21999591)
1. Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria?
Landman MP; Feurer ID; Pinson CW; Moore DE
HPB (Oxford); 2011 Nov; 13(11):783-91. PubMed ID: 21999591
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
3. The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma.
Spolverato G; Vitale A; Ejaz A; Kim Y; Maithel SK; Cosgrove DP; Pawlik TM
World J Surg; 2015 Jun; 39(6):1474-84. PubMed ID: 25665675
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD
J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria.
Lim KC; Wang VW; Siddiqui FJ; Shi L; Chan ES; Oh HC; Tan SB; Chow PK
Hepatology; 2015 Jan; 61(1):227-37. PubMed ID: 24638991
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study.
Pollom EL; Lee K; Durkee BY; Grade M; Mokhtari DA; Wahl DR; Feng M; Kothary N; Koong AC; Owens DK; Goldhaber-Fiebert J; Chang DT
Radiology; 2017 May; 283(2):460-468. PubMed ID: 28045603
[TBL] [Abstract][Full Text] [Related]
7. Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.
Vitale A; Farinati F; Burra P; Trevisani F; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Sacco R; Morisco F; Missale G; Foschi FG; Gasbarrini A; Svegliati Baroni G; Virdone R; Chiaramonte M; Spolverato G; Cillo U;
Liver Transpl; 2015 Oct; 21(10):1250-8. PubMed ID: 26183802
[TBL] [Abstract][Full Text] [Related]
8. Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
Cadier B; Bulsei J; Nahon P; Seror O; Laurent A; Rosa I; Layese R; Costentin C; Cagnot C; Durand-Zaleski I; Chevreul K;
Hepatology; 2017 Apr; 65(4):1237-1248. PubMed ID: 28176349
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM
Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460
[TBL] [Abstract][Full Text] [Related]
10. Survival and cost-effectiveness analysis of competing strategies in the management of small hepatocellular carcinoma.
Naugler WE; Sonnenberg A
Liver Transpl; 2010 Oct; 16(10):1186-94. PubMed ID: 20879017
[TBL] [Abstract][Full Text] [Related]
11. Results of salvage liver transplantation.
Guerrini GP; Gerunda GE; Montalti R; Ballarin R; Cautero N; De Ruvo N; Spaggiari M; Di Benedetto F
Liver Int; 2014 Jul; 34(6):e96-e104. PubMed ID: 24517642
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances.
Nouso K; Tanaka H; Uematsu S; Shiraga K; Okamoto R; Onishi H; Nakamura S; Kobayashi Y; Araki Y; Aoki N; Shiratori Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):437-44. PubMed ID: 17683496
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation.
Poon RT; Fan ST; Lo CM; Liu CL; Wong J
Ann Surg; 2002 Mar; 235(3):373-82. PubMed ID: 11882759
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis.
Patel D; Terrault NA; Yao FY; Bass NM; Ladabaum U
Clin Gastroenterol Hepatol; 2005 Jan; 3(1):75-84. PubMed ID: 15645408
[TBL] [Abstract][Full Text] [Related]
15. Current surgical treatment strategies for hepatocellular carcinoma in North America.
Khan AS; Fowler KJ; Chapman WC
World J Gastroenterol; 2014 Nov; 20(41):15007-17. PubMed ID: 25386049
[TBL] [Abstract][Full Text] [Related]
16. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis.
Majno PE; Sarasin FP; Mentha G; Hadengue A
Hepatology; 2000 Apr; 31(4):899-906. PubMed ID: 10733546
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
[TBL] [Abstract][Full Text] [Related]
18. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.
Zhang X; Li C; Wen T; Yan L; Li B; Yang J; Wang W; Xu M; Lu W; Jiang L
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):933-40. PubMed ID: 25933127
[TBL] [Abstract][Full Text] [Related]
19. Primary results of salvage liver transplantation in the patients with unresectable recurrent hepatocellular carcinoma after initial liver resection.
Liang BY; Huang ZY; Zhou SJ; Hou P; Wang SF; Jiang B; Chen XP
Hepatogastroenterology; 2014 Oct; 61(135):2014-20. PubMed ID: 25713904
[TBL] [Abstract][Full Text] [Related]
20. Survival benefit of transplantation for recurrence of hepatocellular carcinoma after liver resection.
Tuci F; Vitale A; D'Amico F; Gringeri E; Neri D; Zanus G; Bassi D; Polacco M; Boetto R; Lodo E; Germani G; Burra P; Angeli P; Cillo U
Transplant Proc; 2014 Sep; 46(7):2287-9. PubMed ID: 25242770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]